Rodríguez-Tornos et al., 2016 - Google Patents
Cux1 enables interhemispheric connections of layer II/III neurons by regulating Kv1-dependent firingRodríguez-Tornos et al., 2016
View HTML- Document ID
- 17994770781837387607
- Author
- Rodríguez-Tornos F
- Briz C
- Weiss L
- Sebastián-Serrano A
- Ares S
- Navarrete M
- Frangeul L
- Galazo M
- Jabaudon D
- Esteban J
- Nieto M
- Publication year
- Publication venue
- Neuron
External Links
Snippet
Neuronal subtype-specific transcription factors (TFs) instruct key features of neuronal function and connectivity. Activity-dependent mechanisms also contribute to wiring and circuit assembly, but whether and how they relate to TF-directed neuronal differentiation is …
- 101700041765 CUX1 0 title abstract description 203
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rodríguez-Tornos et al. | Cux1 enables interhemispheric connections of layer II/III neurons by regulating Kv1-dependent firing | |
Barre et al. | Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning | |
Robin et al. | Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory | |
Kvajo et al. | Altered axonal targeting and short-term plasticity in the hippocampus of Disc1 mutant mice | |
Elias et al. | Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins | |
Audette et al. | Rapid plasticity of higher-order thalamocortical inputs during sensory learning | |
Leuner et al. | Structural plasticity and hippocampal function | |
Martinowich et al. | Interaction between BDNF and serotonin: role in mood disorders | |
Park et al. | Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1 | |
Meer et al. | Identification of a cis-acting element that localizes mRNA to synapses | |
Miller et al. | Birdsong decreases protein levels of FoxP2, a molecule required for human speech | |
Huang et al. | Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala | |
McReynolds et al. | What does the Fos say? Using Fos-based approaches to understand the contribution of stress to substance use disorders | |
Ungless et al. | Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons | |
Xie et al. | Knockdown of sodium channel NaV1. 6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia | |
Sandi | Stress and cognition | |
Han et al. | A subpopulation of nociceptors specifically linked to itch | |
Boersma et al. | A requirement for nuclear factor-κB in developmental and plasticity-associated synaptogenesis | |
Benedetti et al. | Functional integration of neuronal precursors in the adult murine piriform cortex | |
Mabb et al. | Topoisomerase 1 inhibition reversibly impairs synaptic function | |
Zhang et al. | mGluR 1, 5 activation improves network asynchrony and GABAergic synapse attenuation in the amygdala: implication for anxiety-like behavior in DBA/2 mice | |
Grasselli et al. | Impaired sprouting and axonal atrophy in cerebellar climbing fibres following in vivo silencing of the growth-associated protein GAP-43 | |
He et al. | Gating of hippocampal rhythms and memory by synaptic plasticity in inhibitory interneurons | |
Chen et al. | P2X7 receptors in satellite glial cells mediate high functional expression of P2X3 receptors in immature dorsal root ganglion neurons | |
Reyes et al. | Social stress engages neurochemically-distinct afferents to the rat locus coeruleus depending on coping strategy |